Rate-limiting enzyme in the methyl cycle
Methylenetetrahydrofolate reductase (MTHFR ) is the rate-limiting enzyme in the methyl cycle, and it is encoded by the MTHFR gene .[ 5] Methylenetetrahydrofolate reductase catalyzes the conversion of 5,10-methylenetetrahydrofolate to 5-methyltetrahydrofolate , a cosubstrate for homocysteine remethylation to methionine . Natural variation in this gene is common in otherwise healthy people. Although some variants have been reported to influence susceptibility to occlusive vascular disease , neural tube defects , Alzheimer's disease and other forms of dementia , colon cancer , and acute leukemia , findings from small early studies have not been reproduced. Some mutations in this gene are associated with methylenetetrahydrofolate reductase deficiency .[ 6] [ 7] [ 8] Complex I deficiency with recessive spastic paraparesis has also been linked to MTHFR variants. In addition, the aberrant promoter hypermethylation of this gene is associated with male infertility and recurrent spontaneous abortion .[ 9] [ 10]
^ a b c GRCh38: Ensembl release 89: ENSG00000177000 – Ensembl , May 2017
^ a b c GRCm38: Ensembl release 89: ENSMUSG00000029009 – Ensembl , May 2017
^ "Human PubMed Reference:" . National Center for Biotechnology Information, U.S. National Library of Medicine .
^ "Mouse PubMed Reference:" . National Center for Biotechnology Information, U.S. National Library of Medicine .
^ Goyette P, Sumner JS, Milos R, Duncan AM, Rosenblatt DS, Matthews RG, Rozen R (June 1994). "Human methylenetetrahydrofolate reductase: isolation of cDNA, mapping and mutation identification". Nature Genetics . 7 (2): 195–200. doi :10.1038/ng0694-195 . PMID 7920641 . S2CID 23877329 .
^ "Entrez Gene: MTHFR methylene tetrahydrofolate reductase (NAD(P)H)" .
^ Födinger M, Hörl WH, Sunder-Plassmann G (2000). "Molecular biology of 5,10-methylenetetrahydrofolate reductase". Journal of Nephrology . 13 (1): 20–33. PMID 10720211 .
^ Trimmer EE (2013). "Methylenetetrahydrofolate reductase: biochemical characterization and medical significance". Current Pharmaceutical Design . 19 (14): 2574–93. doi :10.2174/1381612811319140008 . PMID 23116396 .
^ Cite error: The named reference Rotondo_2012
was invoked but never defined (see the help page ).
^ Rotondo JC, Selvatici R, Di Domenico M, Marci R, Vesce F, Tognon M, Martini F (September 2013). "Methylation loss at H19 imprinted gene correlates with methylenetetrahydrofolate reductase gene promoter hypermethylation in semen samples from infertile males" . Epigenetics . 8 (9): 990–7. doi :10.4161/epi.25798 . PMC 3883776 . PMID 23975186 .